Pasteuria Bioscience

Alachua, United States Founded: 2003 • Age: 23 yrs Acquired By Syngenta
Nematode control products

About Pasteuria Bioscience

Pasteuria Bioscience is a Chemicals & Materials company based in Alachua (United States) founded in 2003, and was acquired by Syngenta in September 2011. Nematode control products. It operates in the Chemicals & Materials and Agriculture sectors. Pasteuria Bioscience has raised $9.98 million across 3 funding rounds from investors including Syngenta, Life Sciences Partners and Advantage Capital. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Biologicals. Its competitors include Vestaron, Arysta LifeScience and Cultiva; 2 of its 3 listed competitors have raised funding.

Company details

Pasteuria Bioscience was founded in 2003 in Alachua, United States, with operations centered in agricultural biotechnology. Biological nematicides are developed from naturally occurring soil bacteria, Pasteuria spp., including Pasteuria penetrans. These target nematodes such as root-knot and sting species, affecting diverse turf and crop applications across agriculture. The domain pasteuriabio.com supports related activities.

  • Headquarters Alachua, United States
  • Stage Acquired
  • Sectors
    Chemicals & Materials
    Agriculture
  • Website pasteuriabio.com
  • Acquired by Syngenta (Sep 2011)
Key Metrics
  • Total Equity Funding
    $9.98M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.88M (USD), Series B

    Sep 2010

  • Investors
    Syngenta

    & 3 more

  • Acquired by
    Syngenta

    (Sep 2011)

Funding Insights of Pasteuria Bioscience

Pasteuria Bioscience has successfully raised a total of $9.98M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $1.88 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $9.98M
  • Total Rounds 3
  • Last Round Series B β€” $1.88M
  • First Round $5.3M

    (May 2007)

  • Investors Count 3

All 3 funding rounds of Pasteuria Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2010$1.88MSeries B––
–
Jul 2009$2.8MSeries B–Advantage Capital, Life Sciences Partners
–
May 2007$5.3MSeries B–Life Sciences Partners
Valuation history

4 investors in total: 4 institutional.

Investors in Pasteuria Bioscience

Pasteuria Bioscience has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Syngenta, Life Sciences Partners and Advantage Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investment firm
advantagecap.comNew Orleans, United States
Private equity investments in life sciences businesses are managed.
1998lspvc.comAmsterdam, Netherlands
Early stage venture opportunities are targeted by the firm.
gulfshorecap.comNaples, United States
Crop protection solutions and hybrid seeds are provided for farming.
2000syngenta.comBasel, Switzerland
Premium access

Investor details for Pasteuria Bioscience

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Pasteuria Bioscience

4 dated milestones of Pasteuria Bioscience across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pasteuria Bioscience is founded.
  2. Funding First funding round of $5.3M.
  3. Funding Latest funding round, Series B, of $1.9M.
  4. Exit Acquired by Syngenta.

Competitors of Pasteuria Bioscience

Pasteuria Bioscience has 3 listed competitors in our database, 2 of them funded. They include Vestaron, Arysta LifeScience and Cultiva.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
vestaron.com2001Kalamazoo, United States$286.68M90
Biological insecticides and pesticides are developed from spider peptides.
arystalifescience.com2001Cary, United States274
Chemical and bio-fertilizers are produced and supplied by the company.
cultiva.com1999Las Vegas, United States$8.82M12
Biological plant protectants are manufactured and distributed by Cultiva.
Premium access

Detailed competitors of Pasteuria Bioscience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Chemicals Tech

3 companies that operate in the same segment as Pasteuria Bioscience (Chemicals Tech) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Microbe-based plant protection products and yield optimization services are provided.
2013Boston, Massachusetts, United StatesUSD 1.4 B1,316
Conductive nanocoatings are delivered via atomic layer deposition technology.
2013Boulder, Colorado, United StatesUSD 202.75 M
Sustainable bio-based chemicals are manufactured using a proprietary platform.
2016Houston, Texas, United StatesUSD 656.05 M133
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pasteuria Bioscience

Premium access

Complete news archive for Pasteuria Bioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pasteuria Bioscience

Pasteuria Bioscience was founded in 2003 and raised its 1st funding round 4 years after it was founded.

Pasteuria Bioscience is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.

Pasteuria Bioscience is a funded company, having raised a total of $9.98M across 3 funding rounds to date. The company's 1st funding round was a Series B of $5.3M, raised on May 2007.

Pasteuria Bioscience was founded in 2003 in Alachua, United States, with operations centered in agricultural biotechnology. Biological nematicides are developed from naturally occurring soil bacteria, Pasteuria spp., including Pasteuria penetrans. These target nematodes such as root-knot and sting species, affecting diverse turf and crop applications across agriculture. The domain pasteuriabio.com supports related activities.

Pasteuria Bioscience's top competitors include Vestaron, Arysta LifeScience and Cultiva.

Pasteuria Bioscience has 4 investors. Key investors include Syngenta, Life Sciences Partners, Advantage Capital, and Florida Gulfshore Capital.

Yes. Pasteuria Bioscience was acquired by Syngenta in September 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available